Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
Status:
Completed
Trial end date:
2017-06-21
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of FG-3019 in subjects with Idiopathic Pulmonary
Fibrosis (IPF) and the efficacy of FG-3019 for attenuating fibrosis in these subjects.